View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Pembrolizumab 200, Bladder Cancer, adjuvant
Protocol-ID: 2693 V1.0 (Mini), PEMB200, Bladder Cancer, adj.Indication(s)
- Bladder Cancer (non-muscle invasive, High risk); ICD-10 C67.-
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 23.08.2024